Suppression of human immunodeficiency virus replication during acute measles

被引:61
作者
Moss, WJ
Ryon, JJ
Monze, M
Cutts, F
Quinn, TC
Griffin, DE
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA
[4] NIAID, NIH, Bethesda, MD 20892 USA
[5] Univ Teaching Hosp, Virol Lab, Lusaka, Zambia
[6] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England
关键词
D O I
10.1086/340027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the effect of measles virus coinfection on plasma human immunodeficiency virus (HIV) RNA levels, a prospective study of hospitalized children with measles was conducted between January 1998 and October 2000 in Lusaka, Zambia. Plasma HIV RNA levels were measured during acute measles and 1 month after hospital discharge. The median plasma HIV RNA level in 33 children with measles who were followed longitudinally was 5339 copies/mL at study entry, 60, 121 copies/mL at hospital discharge, and 387, 148 copies/mL at 1-month follow-up. The median plasma HIV RNA level in children without acute illness was 228,454 copies/mL. Plasma levels of immune activation markers were elevated during the period of reduced plasma HIV RNA. Plasma levels of several potential HIV suppressive factors also were elevated during acute measles. HIV replication is transiently suppressed during acute measles at a time of intense immune activation.
引用
收藏
页码:1035 / 1042
页数:8
相关论文
共 66 条
[1]   Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants [J].
Abrams, EJ ;
Weedon, J ;
Steketee, RW ;
Lambert, G ;
Bamji, M ;
Brown, T ;
Kalish, ML ;
Schoenbaum, EE ;
Thomas, PA ;
Thea, DM .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) :101-108
[2]  
Akramuzzaman SM, 2000, AM J EPIDEMIOL, V151, P723, DOI 10.1093/oxfordjournals.aje.a010267
[3]  
AKRIDGE RE, 1994, J IMMUNOL, V153, P5782
[4]   Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression [J].
Amiel, C ;
Darcissac, E ;
Truong, MJ ;
Dewulf, J ;
Loyens, M ;
Mouton, Y ;
Capron, N ;
Bahr, GM .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :83-91
[5]   Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures [J].
Asada, H ;
Klaus-Kovtun, V ;
Golding, H ;
Katz, SI ;
Blauvelt, A .
JOURNAL OF VIROLOGY, 1999, 73 (05) :4019-4028
[6]   Measles virus infection in rhesus macaques: Altered immune responses and comparison of the virulence of six different virus strains [J].
Auwaerter, PG ;
Rota, PA ;
Elkins, WR ;
Adams, RJ ;
DeLozier, T ;
Shi, YQ ;
Bellini, WJ ;
Murphy, BR ;
Griffin, DE .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) :950-958
[7]  
BALER M, 1995, NATURE, V378, P563
[8]   Virus levels in untreated African infants infected with human immunodeficiency virus type 1 [J].
Biggar, RJ ;
Janes, M ;
Pilon, R ;
Miotti, P ;
Taha, TET ;
Broadhead, R ;
Mtimivalye, L ;
Kumwenda, N ;
Cassol, S .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) :1838-1843
[9]   Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine [J].
Brichacek, B ;
Swindells, S ;
Janoff, EN ;
Pirruccello, S ;
Stevenson, M .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1191-1199
[10]   Interleukin 16: implications for CD4 functions and HIV-1 progression [J].
Center, DM ;
Kornfeld, H ;
Ryan, TC ;
Cruikshank, WW .
IMMUNOLOGY TODAY, 2000, 21 (06) :273-280